JPRN-UMIN000022505已完成未知
Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung cancer - Study of biomarkers predicting response to nivolumab in NSCLC
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine0 个研究点目标入组 200 人开始时间: 2016年6月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Combined autoimmune disease or history of recurrent autoimmune disease 2. Interstitial lung disease 3. Severe medical comorbidities 4. Uncontrolled brain metastases
研究者
相似试验
招募中
不适用
Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancerunresectable or recurrent non-small cell lung cancerJPRN-UMIN000026040Kagoshima University90
已完成
2 期
A validation study of biomarkers to predict responders to non-pharmacological multimodal program for advanced cancerson-small-cell lung and pancreatic cancerJPRN-UMIN000033574Department of Respirology, Kyoto Prefectual University of Medicine80
已完成
不适用
Exploratory study for biomarkers to predict efficacy and toxicity to Sorafenib in patients with advanced hepatocellular carcinomaHepatocellulara carcinomaJPRN-UMIN000008808ational Cancer Center Hospital100
招募中
不适用
An exploratory prospective study of the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with Pembrolizumab.solid cancerJPRN-UMIN000028474Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.30
已完成
不适用
Identification of biomarkers that predict responsiveness to Dupilumab among severe asthmaasthmaJPRN-UMIN000041915ational Hospital Organization Tokyo National Hospital15